Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Eleven Biotherapeutics Inc (NASDAQ:EBIO)

0.6504
Delayed Data
As of Dec 13
 -0.0007 / -0.11%
Today’s Change
0.62
Today|||52-Week Range
2.54
-65.95%
Year-to-Date
No recent news for Eleven Biotherapeutics Inc.

Today’s Trading

Previous close0.65
Today’s open0.68
Day’s range0.64 - 0.68
Volume585,139
Average volume (3 months)745,345
Market cap$20.7M
Data as of 4:00pm ET, 12/13/2017

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)-2,155.56%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+2,928.38%
P/E ratioNM
Price/Sales1.38
Price/Book0.41

Competitors

 Today’s
change
Today’s
% change
VICLVical Inc+0.05+2.81%
NVUSNovus Therapeutics I...-0.13-2.91%
JAGXJaguar Health Inc-0.00-3.60%
ITEKInotek Pharmaceutica...-0.13-5.33%
Data as of 4:00pm ET, 12/13/2017

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$30.0M
Annual profit (last year)$1.9M
Net profit margin6.31%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Stephen Allen Hurly
Chief Financial Officer
Richard F. Fitzgerald
Corporate headquarters
Cambridge, Massachusetts

Forecasts